Yazji Salim Insider Trades

Insider Trading History

Track insider trading activity for Yazji Salim. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $7.48k 14,200 shares
Last Trade
Feb 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$130k 14,200 shares
$9.18
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $67.7k 128,635 shares
Last Trade
Jan 03, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$196k 19,742 shares
$9.92
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Oct 02, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.38M 711,475 shares
$6.16
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $187k 354,400 shares
Last Trade
Oct 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.82M 782,075 shares
$6.16
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $78.1k 148,377 shares
Last Trade
Jul 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$116k 16,299 shares
$7.11
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $86.7k 164,676 shares
Last Trade
Apr 14, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$31.2k 5,000 shares
$6.25
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $84.1k 159,676 shares
Last Trade
Apr 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$56.9k 10,000 shares
$5.69
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $78.8k 149,676 shares
Last Trade
Apr 12, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$55.2k 10,000 shares
$5.52
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $111k 210,000 shares
Last Trade
Feb 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.03M 210,000 shares
$19.20
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $73.6k 139,676 shares
Last Trade
Jan 03, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$203k 9,961 shares
$20.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $29k 55,000 shares
Last Trade
Jul 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.14M 55,000 shares
$20.80
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $35.4k 67,137 shares
Last Trade
Jan 27, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$334k 10,000 shares
$33.40
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $48.5k 92,075 shares
Last Trade
Jan 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.57M 92,075 shares
$38.80
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $30.1k 57,137 shares
Last Trade
Jan 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.78M 57,137 shares
$48.60
$0.53
Oncternal Therapeutics
Oncternal Therapeutics ONCT
Chief Medical Officer
Holding Value $0 0 shares
Last Trade
May 25, 2021 Sale
$43.7M 425,000 shares
$102.80
$0.53

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up